StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-19 | $16.04 | $16.54 | +3.12% | 1.4M |
| 05-20 | $16.43 | $16.69 | +1.58% | 1.4M |
| 05-21 | $16.50 | $16.99 | +2.97% | 1.5M |
| 05-22 | $16.99 | $17.25 | +1.53% | 1.5M |
| 05-26 | $17.32 | $17.48 | +0.89% | 0.3M |
Accelerant Holdings operates as a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners. The company operates in three segments: Exchange Services, MGA Operations, and Underwriting. The majority of its revenue is generated from the Underwriting segment, which contains all revenue and expenses associated with the underwriting of insurance policies and assumption of reinsurance policies issued or accepted by Accelerant's consolidated insurance and reinsurance companies. Geographically, it operates in North America, the UK, and the EU, out of which it derives maximum revenue from North America.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $273.30M | $912.90M | $664.50M | $397.10M |
Operating Income | $2.00M | $-1.32B | $-1.32B | $37.80M |
Net Income | $-4.10M | $-1.35B | $-1.35B | $15.30M |
EPS (Diluted) | $-0.02 | $-7.49 | $-7.93 | $0.07 |
Total Assets | $8.60B | $8.26B | $7.86B | $7.50B |
Total Liabilities | $7.88B | $7.54B | $7.16B | $7.01B |
Cash & Equivalents | $1.45B | $1.72B | $1.60B | $1.39B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 221.98M | 190.26M | 179.62M | 166.19M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.